Mirum Pharmaceuticals (MIRM) Non-Current Assets (2019 - 2026)

Mirum Pharmaceuticals' Non-Current Assets history runs 8 years deep, the most recent figure standing at $321.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 15.05% year-over-year to $321.5 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 0.88% YoY), while the FY2025 annual figure was $293.1 million, up 5.45% from the prior year.
• Non-Current Assets was $321.5 million for Q1 2026 at Mirum Pharmaceuticals, up from $293.1 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $321.5 million in Q1 2026 to a low of $60.1 million in Q2 2023.
• Historically, Non-Current Assets has averaged $227.2 million across 5 years, with a median of $262.1 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets soared 2639.19% in 2022, then slumped 59.95% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $162.7 million in 2022, then surged by 59.26% to $259.1 million in 2023, then grew by 7.29% to $278.0 million in 2024, then grew by 5.45% to $293.1 million in 2025, then grew by 9.67% to $321.5 million in 2026.
• The last three Non-Current Assets figures came in at $321.5 million (Q1 2026), $293.1 million (Q4 2025), and $254.5 million (Q3 2025), per Business Quant data.